Cargando…
Efficacy of aldose reductase inhibitors is affected by oxidative stress induced under X-ray irradiation
Human aldose reductase (hAR, AKR1B1) has been explored as drug target since the 1980s for its implication in diabetic complications. An activated form of hAR was found in cells from diabetic patients, showing a reduced sensitivity to inhibitors in clinical trials, which may prevent its pharmacologic...
Autores principales: | Castellví, Albert, Crespo, Isidro, Crosas, Eva, Cámara-Artigas, Ana, Gavira, José A., Aranda, Miguel A. G., Parés, Xavier, Farrés, Jaume, Juanhuix, Judith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395642/ https://www.ncbi.nlm.nih.gov/pubmed/30816220 http://dx.doi.org/10.1038/s41598-019-39722-0 |
Ejemplares similares
-
Structural and biochemical evidence that ATP inhibits the cancer biomarker human aldehyde dehydrogenase 1A3
por: Castellví, Albert, et al.
Publicado: (2022) -
Perspective on the Structural Basis for Human Aldo-Keto Reductase 1B10 Inhibition
por: Ruiz, Francesc Xavier, et al.
Publicado: (2021) -
Biological Role of Aldo–Keto Reductases in Retinoic Acid Biosynthesis and Signaling
por: Ruiz, F. Xavier, et al.
Publicado: (2012) -
Substrate Specificity, Inhibitor Selectivity and Structure-Function Relationships of Aldo-Keto Reductase 1B15: A Novel Human Retinaldehyde Reductase
por: Giménez-Dejoz, Joan, et al.
Publicado: (2015) -
Physiological and Pathological Roles of Aldose Reductase
por: Singh, Mahavir, et al.
Publicado: (2021)